In this Fierce Pharma article, our CEO Richard Pops discusses how our deep expertise in #neuroscience and advanced molecular design capabilities are fueling our path forward. Read the full article to learn more about the evolution of our company’s focus and how we are working to make a lasting difference for patients: https://lnkd.in/gtRkbcvm
Alkermes
Biotechnology Research
Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience.
About us
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized. Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions. Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers and broader impacted communities. We remain committed to patient engagement, responsible and sustainable operations, and equitable access to quality treatment. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
- Website
-
https://www.alkermes.com/
External link for Alkermes
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Dublin
- Type
- Public Company
- Founded
- 1987
- Specialties
- Pharma, Pharmaceutical, Sales, Marketing, IT, CNS, Addiction, Information technology, Human Resources, Sales, District Sales, Regional Sales, Research & Development, R&D, Manufacturing, Medical Affairs, serious mental illness, biotech, addiction, narcolepsy, neuroscience, sleep disorders, and biotech
Locations
-
Primary
Connaught House
1 Burlington Road
Dublin, IE
-
900 Winter St
Waltham, Massachusetts 02451, US
-
265 Olinger Circle
Wilmington, OH 45177, US
Employees at Alkermes
Updates
-
While Labor Day marks the unofficial end of summer, the fall season often contains many chances for celebration and social events. If you’re planning to attend a gathering sometime this fall, but are in recovery or reevaluating your relationship with alcohol, small changes can make a big difference. The Centers for Disease Control and Prevention shares strategies for drinking less and remembering “the how” this month and beyond. #NationalRecoveryMonth https://lnkd.in/eY4fSYgc
-
Did you know that seven in ten adults who have ever struggled with substance use consider themselves to be recovering or in recovery? Understanding the nuances of recovery can make a difference. This Substance Abuse and Mental Health Services Administration (SAMHSA) resource shares insight on the many pathways to recovery, as well as the four major dimensions of recovery: https://lnkd.in/g8ErD_Bt. #NationalRecoveryMonth
-
-
On #TeamAlkermes, we know that diversity makes us stronger. Hear about how our emphasis on embedding diversity, inclusion and belonging into our work helps us make progress on behalf of the patients we seek to serve.
-
September is #NationalRecoveryMonth: a time to raise awareness about the role of #substanceusedisorder treatment in helping people begin or continue on their recovery journey. Stay tuned to our channels as we share resources and information throughout this month.
-
-
Happy #LaborDay to our U.S. colleagues. Thank you to all of #TeamAlkermes for your work to make a difference on behalf of the patients we serve and the communities where we live and work.
-
-
Today is International Overdose Awareness Day, the world’s largest campaign to end overdose and remember those we've lost to overdose. When it comes to overdose prevention, small steps like educating the public have the potential to make a difference. This #IOAD2024 resource defines what an overdose is, how to spot an active overdose, tips on acting quickly in an overdose situation, and more. #Togetherwecan https://lnkd.in/gKzizie
-
-
#TeamAlkermes members are motivated to make a difference in the lives of patients we seek to serve. Guided by our core values, we work each day to make a real impact. Visit our website to learn more. https://lnkd.in/g8qtR6RC
-
Steve Schiavo, #TeamAlkermes’ Head of HR shared his perspective with HR.com on the importance of building a physically and mentally healthy workplace and outlined some actions leaders can take to enhance employee well-being. Read the article: https://lnkd.in/gt5YwbYu
-
Researchers believe that #narcolepsy, a chronic and rare neurological disorder, is often underdiagnosed due to an overall lack of information. Raising awareness of common symptoms – excessive daytime sleepiness, sleep paralysis, and sleep-related hallucinations – may help achieve earlier diagnosis for those who are impacted daily by the symptoms. Learn more about this condition from Wake Up Narcolepsy: https://lnkd.in/gGgz-ChQ
-